A real-world study evaluating the impact of a patient support program on managing abemaciclib-related diarrhea in HR+/HER2− metastatic breast cancer.
The program improved adherence, patient satisfaction, and quality of life, with no treatment discontinuations.
Authors: Isabel Blancas, Miriam González de la Peña, María Fernández Abad, Silvia Antolín Novoa, Encarna Adrover Cebrián, Rodrigo Sánchez Bayona, Esther Zamora Adelantado, Raquel Andrés Conejero, Sonia del Barco Berrón, Manuel Atienza, Alberto Molero, Silvia Díaz-Cerezo, Clara Pérez-Rambla, F. J. Pérez-Sádaba & Luis Manso
Journal: Clinical and Translational Oncology
Year: 2025